Arecor Therapeutics (AREC) News Today → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free AREC Stock Alerts GBX 127.16 -9.34 (-6.84%) (As of 04:19 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 9, 2024 | lse.co.ukArecor Therapeutics collaborates with Medtronic on novel insulinMay 9, 2024 | finanznachrichten.deArecor Therapeutics plc: Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump deliveryMay 9, 2024 | americanbankingnews.comArecor Therapeutics (LON:AREC) Stock Price Down 1.8%April 23, 2024 | lse.co.ukArecor chief financial officer to leave in July after five yearsApril 18, 2024 | morningstar.comArecor Therapeutics PLC Ordinary Shares ARECApril 2, 2024 | lse.co.ukStrip Tinning shares up as hails "largest ever" glazing orderMarch 14, 2024 | finance.yahoo.comArecor Therapeutics announces collaboration on oral GLP-1 drug for diabetes and obesity treatmentMarch 12, 2024 | lse.co.ukArecor to develop "holy grail" diabetes treatment with partner TRxMarch 12, 2024 | finance.yahoo.comARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITYFebruary 16, 2024 | finance.yahoo.comArecor Therapeutics plc (AREC.L)February 1, 2024 | lse.co.ukArecor Therapeutics hails Arestat as 2023 performance "strong"January 20, 2024 | morningstar.comArecor Therapeutics PLC Ordinary SharesJanuary 18, 2024 | lse.co.ukTRADING UPDATES: Patent boosts for DG Innovate and Arecor TherapeuticsDecember 4, 2023 | lse.co.ukArecor inks co-development deal with global medical companyNovember 17, 2023 | finance.yahoo.comArecor Therapeutics takes major step with first commercial sale of AT220November 2, 2023 | lse.co.ukTRADING UPDATES: Troy Income suspends buyback of sharesSeptember 4, 2023 | lse.co.ukArecor Therapeutics subsidiary Tetris Pharma signs deal with GoodlifeAugust 17, 2023 | lse.co.ukArecor Therapeutics to collaborate with "top 10" pharmaceutical firmJuly 20, 2023 | marketwatch.comArecor Therapeutics Flags Strong 1H ProgressJuly 20, 2023 | finance.yahoo.comArecor: Business UpdateJune 3, 2023 | finance.yahoo.comShareholders in Arecor Therapeutics (LON:AREC) are in the red if they invested a year agoApril 24, 2023 | finance.yahoo.comArecor Therapeutics has "a strong basis to accelerate" growth strategyMarch 14, 2023 | finance.yahoo.comRecent uptick might appease Arecor Therapeutics plc (LON:AREC) institutional owners after losing 16% over the past yearDecember 1, 2022 | msn.comArecor to launch second Phase I clinical trial of AT278 rapid-acting insulin for diabetes patientNovember 10, 2022 | finance.yahoo.comEven after rising 12% this past week, Arecor Therapeutics (LON:AREC) shareholders are still down 43% over the past yearNovember 1, 2022 | finance.yahoo.comTetris Pharma Launches Ogluo® in GermanyOctober 11, 2022 | finance.yahoo.comHeadline results from Phase I clinical trial of ultra-rapid acting insulin candidate AT247 demonstrate significantly accelerated insulin absorption and early exposure compared to gold standard insulins NovoLog® and Fiasp®August 24, 2022 | investing.comArecor Therapeutics PLC (AREC)August 9, 2022 | lse.co.ukIrish industrial output rises 8.5% in June from May, up 26% annuallyAugust 2, 2022 | marketwatch.comArecor Therapeutics to Raise GBP6 Mln Via Discounted Placing to Buy Tetris PharmaJuly 18, 2022 | finance.yahoo.comCompanies Like Arecor Therapeutics (LON:AREC) Are In A Position To Invest In GrowthJuly 16, 2022 | marketwatch.comArecor Therapeutics Says Future Revenue-Generating Collaboration Pipeline StrongJune 3, 2022 | finance.yahoo.comArecor Therapeutics' (LON:AREC) investors will be pleased with their notable 57% return over the last yearMay 31, 2022 | proactiveinvestors.comArecor's Sarah Howell discusses its recent webinar on the need for fast-acting insulinMay 24, 2022 | proactiveinvestors.comArecor’s CEO Sarah Howell previews key diabetes webinar on Thursday 26 MarchMay 18, 2022 | finance.yahoo.comARECOR TO HOST KOL WEBINAR ON THE NEED FOR CONCENTRATED AND RAPID ACTING INSULIN TREATMENTS IN DIABETES CAREApril 28, 2022 | proactiveinvestors.com.auArecor Therapeutics drug has the potential to be best-in-classApril 25, 2022 | proactiveinvestors.com.auArecor Therapeutics has strong pipeline of opportunities aheadApril 12, 2022 | finance.yahoo.comArecor Announces Oral Presentation at Attd 2022 of Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin for DiabetesMarch 28, 2022 | proactiveinvestors.comArecor scoops two awards at CambridgeshireLive Business AwardsMarch 23, 2022 | lse.co.ukTRADING UPDATES: Arecor Therapeutics wins patent approval in USMarch 23, 2022 | marketwatch.comArecor Therapeutics Granted U.S. Patent for Insulin ProductsMarch 23, 2022 | finance.yahoo.comARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULIN PRODUCTSMarch 23, 2022 | proactiveinvestors.comArecor Therapeutics granted US patents to protect specific insulin productsOctober 11, 2021 | morningstar.comArecor Therapeutics Shares Jump as Vaccine Patent Is Upheld by European Patent OfficeSeptember 25, 2021 | msn.comSMALL CAP MOVERS: Arecor Therapeutics rockets after positive trial results; Touchstone Exploration ends drilling campaign with a bangSeptember 25, 2021 | msn.comSMALL CAP MOVERS: Arecor Therapeutics and Touchstone ExplorationSeptember 24, 2021 | finance.yahoo.comPortfolio Update : CorrectionSeptember 22, 2021 | markets.businessinsider.comArecor Therapeutics : Second Price Monitoring ExtnSeptember 21, 2021 | uk.finance.yahoo.comCambridge biotech makes diabetes breakthrough Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now AREC Media Mentions By Week AREC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AREC News Sentiment▼0.410.55▲Average Medical News Sentiment AREC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AREC Articles This Week▼20▲AREC Articles Average Week Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sareum News e-therapeutics News C4X Discovery News Redx Pharma News OKYO Pharma News Hemogenyx Pharmaceuticals News Ondine Biomedical News Oncimmune News OptiBiotix Health News Poolbeg Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AREC) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
